Joginder Pal
Psychiatry · Virginia Beach, VANPI 1194701805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 166 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 30.5% of the total. Reporting peaked in 2019 at $982 and has fallen 96.6% since, to $33 in 2025.
Across 166 payments — averaging $21.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Sunovion Pharmaceuticals Inc.$683
- Johnson & Johnson$433
- Otsuka America Pharmaceutical, Inc.$292
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$138
- Alkermes, Inc.$132
- plus $769 from 17 others
What the payments were for
- Food & beverage$3,48999%
- Education$301%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 51 | $1,072 |
| Sunovion Pharmaceuticals Inc. | 34 | $683 |
| Johnson & Johnson | 8 | $433 |
| Otsuka America Pharmaceutical, Inc. | 15 | $292 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $138 |
| Alkermes, Inc. | 3 | $132 |
| Lundbeck LLC | 7 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $105 |
| Supernus Pharmaceuticals, Inc. | 4 | $82 |
| Jazz Pharmaceuticals Inc. | 5 | $78 |
| Neos Therapeutics, LP | 5 | $66 |
| Tris Pharma Inc | 3 | $59 |
| Ironshore Pharmaceuticals Inc. | 2 | $42 |
| Corium, LLC | 2 | $41 |
| Noven Therapeutics, LLC | 2 | $31 |
| Shire North American Group Inc | 2 | $26 |
| Neurocrine Biosciences, Inc. | 2 | $24 |
| Avanir Pharmaceuticals, Inc. | 2 | $24 |
| Bausch Health US, LLC | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $12 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,519 in reported general payments places this provider in the 85th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $729 |
| Quetiapine Fumarate | 12 | $239 |
| Escitalopram Oxalate | 21 | $208 |
| Bupropion Hcl SrBupropion Hcl | 22 | $180 |
| Mirtazapine | 13 | $161 |
| Trazodone Hcl | 14 | $120 |
| Buspirone Hcl | 18 | $93 |
| Lamotrigine | 12 | $0 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Virginia Beach
- William YetterVirginia Beach$312K
- Mark SchreiberVirginia Beach$29K
- Angelina Espinosa GuanzonVirginia Beach$21K
- Maria CenzonVirginia Beach$17K
- Jolie HinnenkampVirginia Beach$12K
- Elizabeth KaminVirginia Beach$11K
- Stephen CunninghamVirginia Beach$10K
- Heather RoweVirginia Beach$10K
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.